The degradation of tau by selective autophagy
The degradation of tau by selective autophagy
批准号:
9395850
负责人:
Gail V. W. Johnson
金额:
$33.69万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-07-01 至 2021-04-30
关键词:
Adaptor Signaling ProteinAddressAffectAgeAgingAlpha CellAutophagocytosisAutophagosomeAwarenessBCL2 geneBasic ScienceBinding ProteinsBiologyBrainCell divisionCellsClientCollectionComplementComplexDataDegradation PathwayDependenceDiseaseElementsExcisionExhibitsFoundationsFutureHealthIn SituKnowledgeMaintenanceMediatingMediator of activation proteinMicrotubulesModelingMolecularMolecular ChaperonesNervous system structureNeuronsNeurosciencesOrganismPathway interactionsPharmacologyPhysiological ProcessesPlayProcessProsencephalonProteinsProteomeQuality ControlRegulationResearchResearch ProposalsResourcesRodentRoleStress-Induced ProteinStructureSystemTestingVacuoleVitronectinbaseclinically relevantgenetic approachin vivointerestmembermouse modelnormal agingpromoterproteostasisresponsesmall hairpin RNAtau Proteinstau conformation
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This is a fundamental basic research proposal that is focused on understanding the role of Bcl-
2-associated anthogene 3 (BAG3) in mediating selective autophagy and the turnover of tau in
neurons and how these processes change during aging. Selective autophagy is part of a cell's
protein quality control (PQC) system, which is the collection of cellular pathways that sense
damaged proteins and facilitate their removal. PQC is essential for the maintenance of the
appropriate, functional complement of proteins in a cell. Tau is a neuronally enriched
multifunctional protein. Given the importance of tau in neuronal function, understanding the
PQC processes which regulate phospho-tau species, as well as total tau levels, is of critical
importance. There is a growing awareness that selective autophagy, i.e., the specific recognition
and targeting of client proteins to the developing autophagosome is essential for effective PQC.
Chaperones and co-chaperones, along with the autophagic machinery, are key PQC players in
the process of recognizing and removing damaged proteins. The co-chaperone BAG3 is an
important player in selective autophagy and thus a pivotal player in the PQC system. Recently
we made the exciting discovery that in neurons BAG3 plays a significant role in
facilitating autophagy and directing endogenous, soluble tau to autophagy. This is of
fundamental importance because in healthy neurons autophagy is constitutively active and
plays a significant role in maintaining a functional proteome. BAG3 is a stress-induced protein
that increases during normal aging. It has been suggested that during aging the change in
cellular demands increases the use of autophagy to maintain protein homeostasis, and that
BAG3 plays an essential role in this process. Indeed, it has been documented that during aging
BAG3 levels increase in the rodent brain concurrent with an increased dependence on
autophagy for proteostasis. Therefore, understanding the role of BAG3 in autophagy and how it
functions to facilitate the clearance of soluble tau species is of fundamental significance. The
overall hypothesis of this proposal is that BAG3 is a key mediator of selective autophagy in
neurons and plays a significant role in mediating the clearance of tau. The specific aims of this
proposal are: (1) To test the hypothesis that BAG3 modulates autophagy and tau turnover
in situ and in vivo, and that during aging the dependence on BAG3 to facilitate
autophagy and tau clearance increases, (2) To identify essential features of the BAG3-
chaperone complex that mediate tau clearance, and (3) To characterize the mechanisms
that regulate BAG3 expression and tests their role in autophagy-based clearance of tau
in neurons. Currently little is known about the role of BAG3 in mediating autophagy in neurons,
as well as how it facilitates the turnover of tau; this application addresses these gaps in our
knowledge.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mitochondrial dysfunction and tau pathology in Alzheimer's disease
-
批准号:10805120
-
项目类别:
-
资助金额:$42.35万
-
财政年份:2023
-
负责人:Gail V. W. Johnson
-
依托单位:
Mechanisms of Transglutaminase 2 (TG2)-Mediated Gene Expression in Astrocyte
-
批准号:10293984
-
项目类别:
-
资助金额:$42.35万
-
财政年份:2021
-
负责人:Gail V. W. Johnson
-
依托单位:
BAG3 regulates Rab35 and the ESCRT/endolysosome pathway
-
批准号:10269305
-
项目类别:
-
资助金额:$43.63万
-
财政年份:2021
-
负责人:Gail V. W. Johnson
-
依托单位:
BAG3 regulates Rab35 and the ESCRT/endolysosome pathway
-
批准号:10461933
-
项目类别:
-
资助金额:$43.63万
-
财政年份:2021
-
负责人:Gail V. W. Johnson
-
依托单位:
BAG3 regulates Rab35 and the ESCRT/endolysosome pathway
-
批准号:10667539
-
项目类别:
-
资助金额:$43.63万
-
财政年份:2021
-
负责人:Gail V. W. Johnson
-
依托单位:
Tau Post-Translational Modifications and Mitochondrial Quality Control
-
批准号:10374933
-
项目类别:
-
资助金额:$57.09万
-
财政年份:2020
-
负责人:Gail V. W. Johnson
-
依托单位:
Tau Post-Translational Modifications and Mitochondrial Quality Control
-
批准号:10188394
-
项目类别:
-
资助金额:$57.09万
-
财政年份:2020
-
负责人:Gail V. W. Johnson
-
依托单位:
Tau Post-Translational Modifications and Mitochondrial Quality Control
-
批准号:10601125
-
项目类别:
-
资助金额:$57.09万
-
财政年份:2020
-
负责人:Gail V. W. Johnson
-
依托单位:
Tau protein turnover and mitochondrial stress responses
-
批准号:9761421
-
项目类别:
-
资助金额:$23.1万
-
财政年份:2018
-
负责人:Gail V. W. Johnson
-
依托单位:
The degradation of tau by selective autophagy
-
批准号:9918995
-
项目类别:
-
资助金额:$39.68万
-
财政年份:2017
-
负责人:Gail V. W. Johnson
-
依托单位:
The attenuation of ischemic injury by transglutaminase 2
-
批准号:8652526
-
项目类别:
-
资助金额:$2.57万
-
财政年份:2013
-
负责人:Gail V. W. Johnson
-
依托单位:
Autophagy, p62 and the Nrf2 Intersect to Protect Against Tau Toxicity
-
批准号:8463265
-
项目类别:
-
资助金额:$18.64万
-
财政年份:2012
-
负责人:Gail V. W. Johnson
-
依托单位:
Autophagy, p62 and the Nrf2 Intersect to Protect Against Tau Toxicity
-
批准号:8369614
-
项目类别:
-
资助金额:$23.18万
-
财政年份:2012
-
负责人:Gail V. W. Johnson
-
依托单位:
The attenuation of ischemic injury by transglutaminase 2
-
批准号:8184138
-
项目类别:
-
资助金额:$33.74万
-
财政年份:2011
-
负责人:Gail V. W. Johnson
-
依托单位:
The attenuation of ischemic injury by transglutaminase 2
-
批准号:8401144
-
项目类别:
-
资助金额:$32.61万
-
财政年份:2011
-
负责人:Gail V. W. Johnson
-
依托单位:
The attenuation of ischemic injury by transglutaminase 2
-
批准号:8260315
-
项目类别:
-
资助金额:$33.8万
-
财政年份:2011
-
负责人:Gail V. W. Johnson
-
依托单位:
The attenuation of ischemic injury by transglutaminase 2
-
批准号:8603292
-
项目类别:
-
资助金额:$38.54万
-
财政年份:2011
-
负责人:Gail V. W. Johnson
-
依托单位:
Posttranslational processing of tau: function & dysfunc.
-
批准号:6897351
-
项目类别:
-
资助金额:$26.86万
-
财政年份:2005
-
负责人:Gail V. W. Johnson
-
依托单位:
Core--Molecular detection
-
批准号:7090250
-
项目类别:
-
资助金额:$20.36万
-
财政年份:2005
-
负责人:Gail V. W. Johnson
-
依托单位:
Posttranslational processing of tau: function & dysfunc.
-
批准号:7454783
-
项目类别:
-
资助金额:$12.45万
-
财政年份:2005
-
负责人:Gail V. W. Johnson
-
依托单位:
海外基金